pembrolizumab,luspatercept,ribociclib,epoetin alfa
merck,novartis,bms
['lusp', 'breast', 'pembro', ' ribo', 'ribociclib']
in today's nejm group coverage of #asco23:
- adjuvant ribociclib &amp; hr+/her2 early breast cancer
- luspatercept &amp; myelodysplastic syndromes - pembrolizumab + chemo in cervical cancer
read the full issue: 
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.